Wallace Zachary S, Lu Na, Miloslavsky Eli, Unizony Sebastian, Stone John H, Choi Hyon K
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Arthritis Care Res (Hoboken). 2017 Jun;69(6):915-921. doi: 10.1002/acr.22976. Epub 2017 Apr 28.
Granulomatosis with polyangiitis (Wegener's) (GPA) is a type of antineutrophil cytoplasmic antibody-associated vasculitis that often entails severe end-organ damage and treatment-related complications that frequently lead to hospitalization and death. Nationwide trends in hospitalizations and in-hospital mortality over the past 2 decades are unknown and were evaluated in this study.
Using the National Inpatient Sample, the largest all-payer inpatient database in the US, trends in hospitalizations with a discharge diagnosis of GPA (formerly Wegener's granulomatosis; International Classification of Disease, Ninth Revision, Clinical Modification code 446.4) between 1993 and 2011 were studied. Analyses were performed using hospital-level sampling weights to obtain US national estimates.
From 1993 to 2011, the annual hospitalization rate for patients with a principal diagnosis of GPA increased by 24%, from 5.1 to 6.3 per 1 million US persons (P < 0.0001 for trend); however, in-hospital deaths in this group declined by 73%, from 9.1% to 2.5% (P < 0.0001 for trend), resulting in a 66% net reduction in the annual in-hospital mortality rate. The median length of stay declined by 20%, from 6.9 days in 1993 to 5.5 days in 2011 (P = 0.0002 for trend). Infection was the most common principal discharge diagnosis when GPA was a secondary diagnosis, including among those who died during hospitalization.
The findings from these nationally representative, contemporary inpatient data indicate that the in-hospital mortality of GPA has declined substantially over the past 2 decades, while the overall hospitalization rate for GPA increased slightly. Infection remains a common principal hospitalization diagnosis among GPA patients, including hospitalizations resulting in mortality.
肉芽肿性多血管炎(韦格纳氏)(GPA)是一种抗中性粒细胞胞浆抗体相关性血管炎,常导致严重的终末器官损害及与治疗相关的并发症,这些并发症常导致住院和死亡。过去20年全国范围内的住院率和院内死亡率趋势尚不清楚,本研究对其进行了评估。
利用美国最大的全付费者住院数据库——国家住院样本,研究了1993年至2011年间出院诊断为GPA(原韦格纳肉芽肿;国际疾病分类第九版临床修订本代码446.4)的住院趋势。采用医院层面的抽样权重进行分析以获得美国全国估计数。
1993年至2011年,主要诊断为GPA的患者年住院率上升了24%,从每100万美国人中的5.1例增至6.3例(趋势P<0.0001);然而,该组的院内死亡下降了73%,从9.1%降至2.5%(趋势P<0.0001),导致年院内死亡率净下降66%。住院时间中位数下降了20%,从1993年的6.9天降至2011年的5.5天(趋势P=0.0002)。当GPA为次要诊断时,感染是最常见的主要出院诊断,包括在住院期间死亡的患者。
这些具有全国代表性的当代住院数据表明,在过去20年中,GPA的院内死亡率大幅下降,而GPA的总体住院率略有上升。感染仍然是GPA患者常见的主要住院诊断,包括导致死亡的住院病例。